XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCIAL INSTRUMENTS (Tables)
 9 Months Ended
Mar. 31, 2023
Investments, All Other Investments [Abstract]  
SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS

   As of March 31, 2023 
   Cost   Unrealized Gain (Loss)   Fair Value   Cash and Cash Equivalents   Investments 
Cash  $1,370,129   $-        $1,370,129      
Level 1:                         
Money market funds   4,677,872    -   $4,677,872    4,677,872      
Total cash and cash equivalents  $6,048,001   $-   $4,677,872   $6,048,001      
                          
Level 1:                         
Investments  $250,892   $(3,381)  $247,511        $247,511 

 

   As of June 30, 2022 
   Cost   Unrealized Gain (Loss)   Fair Value   Cash and Cash Equivalents   Investments 
Cash  $1,233,608   $-        $1,233,608      
Level 1:                         
Money market funds   15,016,058    -   $15,016,058    15,016,058      
Total cash and cash equivalents  $16,249,666   $-   $15,016,058   $16,249,666      
                          
Level 1:                         
Investments  $245,187   $(5,873)  $239,314        $239,314 
SCHEDULE OF FAIR VALUE OF CONTINGENT CONSIDERATION

As of March 31, 2023, the Company’s contingent consideration liabilities current and non-current balances were as follows:

 

SCHEDULE OF FAIR VALUE OF CONTINGENT CONSIDERATION

                          
   As of March 31, 2023 
   Contingent Consideration at Purchase Date   Consideration Paid   Changes in Fair Value   Fair Value   Contingent Consideration 
Level 3:                         
Contingent consideration, current - S5D  $2,060,300   $(623,300)  $1,535,500   $2,972,500   $2,972,500 
Contingent consideration, current - BLI   1,841,100    -    (823,900)   1,017,200    1,017,200 
Contingent consideration, current - XRT   -    (197,498)   331,786    134,288    134,288 
Total contingent consideration, current portion  $3,901,400   $(820,798)  $1,043,386   $4,123,988   $4,123,988 
                          
Level 3:                         
Contingent consideration, non-current - S5D  $7,108,900   $(735,701)  $(3,770,799)  $2,602,400   $2,602,400 
Contingent consideration, non-current - BLI   4,297,900    -    (380,500)   3,917,400    3,917,400 
Total contingent consideration, net of current portion  $11,406,800   $(735,701)  $(4,151,299)  $6,519,800   $6,519,800 

 

As of June 30, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows:

 

                     
   As of June 30, 2022 
   Contingent Consideration at Purchase Date   Changes in Fair Value   Fair Value   Contingent Consideration 
Level 3:                    
Contingent consideration, current - S5D  $2,060,300   $(662,700)  $1,397,600   $1,397,600 
Contingent consideration, current - AUGGD   -    568,571    568,571    568,571 
Total contingent consideration, current  $2,060,300   $(94,129)  $1,966,171   $1,966,171 
                     
Level 3:                    
Contingent consideration, non-current - S5D  $7,108,900   $(1,768,100)  $5,340,800   $5,340,800